Furthermore, Tomita et al. found that immunogenic peptides from IGF2BP3 effectively kill cancer cells naturally expressing IGF2BP3 through specific cytotoxic T lymphocytes [109]. The gene discussed is IGF2BP3; the disease is cancer.